Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Philipp, Hartrampf"'
Autor:
Rudolf A. Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Takahiro Higuchi, Philipp Hartrampf, Sebastian E. Serfling, Thorsten Derlin, Constantin Lapa, Andreas K. Buck, Markus Essler, Kenneth J. Pienta, Mario A. Eisenberger, Mark C. Markowski, Laura Shinehouse, Rehab AbdAllah, Ali Salavati, Martin A. Lodge, Martin G. Pomper, Michael A. Gorin, Ralph A. Bundschuh, Steven P. Rowe
Publikováno v:
Molecular Imaging, Vol 2022 (2022)
Objectives. In patients with prostate cancer (PC) receiving prostate-specific membrane antigen- (PSMA-) targeted radioligand therapy (RLT), higher baseline standardized uptake values (SUVs) are linked to improved outcome. Thus, readers deciding on RL
Externí odkaz:
https://doaj.org/article/5bfc1256bc1347abb2e5c98b1daffdae
Publikováno v:
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie. 147:249-255
ZusammenfassungNeuroendokrine Neoplasien (NEN) sind seltene, heterogene und typischerweise langsam wachsende Tumoren. Die häufigsten Lokalisationen finden sich im gastro-entero-pankreatischen System (GEP-NEN). NENs werden nach proliferativer Aktivit
Autor:
André Marquardt, Philipp Hartrampf, Philip Kollmannsberger, Antonio G. Solimando, Svenja Meierjohann, Hubert Kübler, Ralf Bargou, Bastian Schilling, Sebastian E. Serfling, Andreas Buck, Rudolf A. Werner, Constantin Lapa, Markus Krebs
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 392
Simple Summary Imaging based on positron emission tomography (PET) is a crucial part of up-to-date cancer care. For this purpose, PET employs and marks target structures at the cellular surface. Recently, C-X-C Motif Chemokine Receptor 4 (CXCR4) and
Publikováno v:
Zentralblatt fur Chirurgie. 147(3)
Neuroendocrine neoplasms (NEN) are rare, heterogeneous, and typically slowly growing tumours. The most common location is the gastro-entero-pancreatic system (GEP-NEN). NENs are classified according to their proliferative activity (Ki-67 index, G1-3)
Autor:
Felix, Kind, Ann-Christin, Eder, Cordula Annette, Jilg, Philipp, Hartrampf, Philipp T, Meyer, Juri, Ruf, Kerstin, Michalski
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Autor:
Wojciech Cytawa, Stefan Kircher, Hubert Kübler, Rudolf A. Werner, Simon Weber, Philipp Hartrampf, Tomasz Bandurski, Piotr Lass, Wojciech Połom, Marcin Matuszewski, Hans-Jürgen Wester, Constantin Lapa, Andreas Rosenwald, Anna Katharina Seitz, Andreas K. Buck
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873747301f610902c0e630b751995469
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/95775
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/95775
Autor:
Jörg Tamihardja, Leonie Zehner, Philipp Hartrampf, Dominik Lisowski, Susanne Kneitz, Sinan Cirsi, Gary Razinskas, Michael Flentje, Bülent Polat
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3766
Simple Summary Patients, who suffer from oligorecurrent prostate cancer with limited nodal involvement, may be offered positron emission tomography (PET)-directed salvage nodal radiotherapy to delay disease progression. This current analysis aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c592bab50decbb9855b6eef8812ceb
https://doi.org/10.3390/cancers14153766
https://doi.org/10.3390/cancers14153766
Autor:
Rudolf A, Werner, Bilêl, Habacha, Susanne, Lütje, Lena, Bundschuh, Takahiro, Higuchi, Philipp, Hartrampf, Sebastian E, Serfling, Thorsten, Derlin, Constantin, Lapa, Andreas K, Buck, Markus, Essler, Kenneth J, Pienta, Mario A, Eisenberger, Mark C, Markowski, Laura, Shinehouse, Rehab, AbdAllah, Ali, Salavati, Martin A, Lodge, Martin G, Pomper, Michael A, Gorin, Ralph A, Bundschuh, Steven P, Rowe
Publikováno v:
Molecular imaging. 2022
In patients with prostate cancer (PC) receiving prostate-specific membrane antigen- (PSMA-) targeted radioligand therapy (RLT), higher baseline standardized uptake values (SUVs) are linked to improved outcome. Thus, readers deciding on RLT must have
Autor:
Wojciech, Cytawa, Stefan, Kircher, Hubert, Kübler, Rudolf A, Werner, Simon, Weber, Philipp, Hartrampf, Tomasz, Bandurski, Piotr, Lass, Wojciech, Połom, Marcin, Matuszewski, Hans-Jürgen, Wester, Constantin, Lapa, Andreas, Rosenwald, Anna Katharina, Seitz, Andreas K, Buck
Publikováno v:
European journal of nuclear medicine and molecular imaging. 49(11)
The purpose of this study was to immunohistochemically validate the primary tumor PSMA expression in prostate cancer (PCa) patients imaged with [The study included 40 men with newly diagnosed treatment-naïve PCa imaged with [Eighty-three percent (33
Autor:
Heribert, Hänscheid, Andreas, Schirbel, Philipp, Hartrampf, Sabrina, Kraus, Rudolf A, Werner, Hermann, Einsele, Hans-Jürgen, Wester, Michael, Lassmann, Martin, Kortüm, Andreas K, Buck
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63(5)
The chemokine receptor 4 (CXCR4), which is overexpressed in many solid and hematologic malignancies, can be targeted for radiopeptide therapy via the antagonist pentixather. The biokinetics and dosimetry of